Announcements Trials
Browse Landscape

Phase

Phase 2 50Phase 3 14Phase 1 9Phase NA 7Phase 1/2 5Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 49Terminated 9Active not recruiting 8Unknown 6Recruiting 6Withdrawn 5

Sponsor Class

OTHER 237INDUSTRY 113NIH 19NETWORK 5OTHER_GOV 2FED 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Stomach Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Hereditary Sensory and Autonomic Neuropathies 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Adenocarcinoma Of Esophagus 1

Interventions

neratinib 1merphos 1hydrocortisone hemisuccinate 1fludarabine phosphate 1conatumumab 1Radiotherapy, Conformal 1Prednisolone 1Oxaliplatin 1Methylprednisolone 1Methotrexate 1Liposomes 1Leucovorin 1Injections 1IL13-PE38 1Hydrocortisone 1Gemcitabine 1Fluorouracil 1Daunorubicin 1Cytarabine 1Cetuximab 1Capecitabine 1CPX-351 1Biopsy 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Withdrawn × NETWORK × Clear all
NCT05320380 2023-09-01

A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Children's Oncology Group

Phase 1/2 Withdrawn
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02344810 2023-05-25

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Eastern Cooperative Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms

NCT01960023 2021-10-27

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer

NSABP Foundation Inc

Phase 1/2 Withdrawn
Gastrointestinal

Hereditary Sensory and Autonomic Neuropathies, Colorectal Neoplasms

NCT01017822 2013-06-24

Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Radiation Therapy Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT00053040 2010-09-24

Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas

Pediatric Brain Tumor Consortium

Phase 1/2 Withdrawn
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡